EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human Cytomegalovirus as a Therapeutic Target in Glioma Stem Cells

Tarek Bou Dargham, Eugene J Vaios iD, Sean Lawler, Kristen Batich iD

Cells · 24.03.2026 · 15 (7) · 575

DOI: 10.3390/cells15070575 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 24.03.2026. Verfasst von Tarek Bou Dargham und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Duke University, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Cytomegalovirus, Glioma, Brain Neoplasms. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Duke Clinical and Translational Science Award, Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO), Duke Cancer Institute (DCI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is the most aggressive tumor among gliomas, and recurrence remains inevitable despite aggressive therapies. Resistance to existing treatment modalities is attributed in part to the presence of glioma stem cells, which comprise a distinct cell subpopulation that sustains cell renewal and tumor evasion through multiple mechanisms. Therapeutic strategies using herpesviruses have been evaluated following the discovery of differential human cytomegalovirus (HCMV) expression in glioblastoma tumor cells. The absence of expression in normal brain tissue led to multiple clinical trials demonstrating the potential clinical utility of targeted HCMV via herpesvirus-based oncolytic therapeutic strategies. This review provides a comprehensive overview of existing studies evaluating the expression and biological significance of HCMV within glioma stem cells. Targeting HCMV in this cellular compartment may disrupt the continuous cellular support and resilience of glioblastoma stem cells, thereby enhancing the efficacy of current treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsCytomegalovirusGliomaBrain NeoplasmsGlioblastomaHumansAnimals

Stichwörter der Autor:innen

glioblastomagliomaglioma stem cellshuman cytomegalovirustargeted therapy

Autor:innen und Institutionen

  • Department of Neurosurgery, Duke University, Durham, NC 27710, USA.
  • The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA.
  • Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
  • Department of Pathology and Laboratory Medicine, Legorreta Cancer Center, Brown University, Providence, RI 02903, USA.

ORCID-Profile: Eugene J Vaios, Kristen Batich

Förderung

  • Duke Clinical and Translational Science Award
  • Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO)
  • Duke Cancer Institute (DCI)
  • Duke SPORE in Brain Cancer
  • Duke Clinical and Translational Science Award (National Institutes of Health
  • Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) Young Investigator Award
  • Duke SPORE in Brain Cancer Career Enhancement Program
  • Duke Cancer Institute (DCI) Pilot Project

Zitieren

APA

Bou Dargham, T., Vaios, E. J., Lawler, S., & Batich, K. (2026). Human Cytomegalovirus as a Therapeutic Target in Glioma Stem Cells. Cells, 15(7), 575. https://doi.org/10.3390/cells15070575

Vancouver

Bou Dargham T, Vaios EJ, Lawler S, Batich K. Human Cytomegalovirus as a Therapeutic Target in Glioma Stem Cells. Cells. 2026;15(7):575. doi:10.3390/cells15070575

BibTeX
@article{BouDargham2026,
  author = {Bou Dargham, Tarek and Vaios, Eugene J and Lawler, Sean and Batich, Kristen},
  title = {Human Cytomegalovirus as a Therapeutic Target in Glioma Stem Cells},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {575},
  doi = {10.3390/cells15070575}
}
Kostenlos starten →